That's all good for me as well. Update/discussion on clinicals is great for those just tuning into Cellceutix.
I know where my confidence level is. Those just starting to DD should tune in as well. AND do their DD not only on the pipeline potential but how well Cellceutix has managed their financials over the years and progressed their pipeline.
It really does matter when comparing other bio's, including MANY that are listed on the small to midcap listings.
Message in reply to:
I agree. I think we will get the std update and trial progress but no big announcements